176 related articles for article (PubMed ID: 18612318)
1. Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease.
Jung KH; Chu K; Lee ST; Park HK; Kim DH; Kim JH; Bahn JJ; Song EC; Kim M; Lee SK; Roh JK
J Cereb Blood Flow Metab; 2008 Nov; 28(11):1795-803. PubMed ID: 18612318
[TBL] [Abstract][Full Text] [Related]
2. Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke.
Chu K; Jung KH; Lee ST; Park HK; Sinn DI; Kim JM; Kim DH; Kim JH; Kim SJ; Song EC; Kim M; Lee SK; Roh JK
Stroke; 2008 May; 39(5):1441-7. PubMed ID: 18356550
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease.
Rafat N; Beck GCh; Peña-Tapia PG; Schmiedek P; Vajkoczy P
Stroke; 2009 Feb; 40(2):432-8. PubMed ID: 19095988
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Superficial Temporal Artery-to-Middle Cerebral Artery Anastomosis in Treating Moyamoya Disease by Reducing Endothelial Progenitor Cells.
Zhang W; Wang X; Wang Z; Shang J; Wang H; Yin G
World Neurosurg; 2016 Sep; 93():365-70. PubMed ID: 27350298
[TBL] [Abstract][Full Text] [Related]
5. Decreased level and defective function of circulating endothelial progenitor cells in children with moyamoya disease.
Kim JH; Jung JH; Phi JH; Kang HS; Kim JE; Chae JH; Kim SJ; Kim YH; Kim YY; Cho BK; Wang KC; Kim SK
J Neurosci Res; 2010 Feb; 88(3):510-8. PubMed ID: 19774676
[TBL] [Abstract][Full Text] [Related]
6. Insufficient production of IL-10 from M2 macrophages impairs in vitro endothelial progenitor cell differentiation in patients with Moyamoya disease.
Nagata E; Masuda H; Nakayama T; Netsu S; Yuzawa H; Fujii N; Kohara S; Sorimachi T; Osada T; Imazeki R; Matsumae M; Asahara T; Takizawa S
Sci Rep; 2019 Nov; 9(1):16752. PubMed ID: 31727941
[TBL] [Abstract][Full Text] [Related]
7. Smooth-muscle progenitor cells isolated from patients with moyamoya disease: novel experimental cell model.
Kang HS; Moon YJ; Kim YY; Park WY; Park AK; Wang KC; Kim JE; Phi JH; Lee JY; Kim SK
J Neurosurg; 2014 Feb; 120(2):415-25. PubMed ID: 24160477
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
9. Spatial relationship between cerebral microbleeds, moyamoya vessels, and hematoma in moyamoya disease.
Kazumata K; Shinbo D; Ito M; Shichinohe H; Kuroda S; Nakayama N; Houkin K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1421-8. PubMed ID: 24529354
[TBL] [Abstract][Full Text] [Related]
10. Impaired functional recovery of endothelial colony-forming cells from moyamoya disease in a chronic cerebral hypoperfusion rat model.
Choi SA; Chong S; Kwak PA; Moon YJ; Jangra A; Phi JH; Lee JY; Park SH; Kim SK
J Neurosurg Pediatr; 2018 Nov; 23(2):204-213. PubMed ID: 30668528
[TBL] [Abstract][Full Text] [Related]
11. Is Quasi-moyamoya Disease a Uniform Disease Entity? A Three-Dimensional Constructive Interference in Steady State Imaging Study.
Yamamoto S; Koh M; Kashiwazaki D; Akioka N; Kuwayama N; Noguchi K; Kuroda S
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1509-16. PubMed ID: 27038981
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of circulating SDF-1α and CD34+ CXCR4+ cells in patients with moyamoya disease.
Ni G; Liu W; Huang X; Zhu S; Yue X; Chen Z; Chen M; Liu X; Xu G
Eur J Neurol; 2011 Nov; 18(11):1304-9. PubMed ID: 21435112
[TBL] [Abstract][Full Text] [Related]
13. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
[TBL] [Abstract][Full Text] [Related]
14. Circulating endothelial progenitor cells and endothelial cells in moyamoya disease.
Bao XY; Fan YN; Liu Y; Wang QN; Zhang Y; Zhu B; Liu B; Duan L
Brain Behav; 2018 Sep; 8(9):e01035. PubMed ID: 30141248
[TBL] [Abstract][Full Text] [Related]
15. Pathological Circulating Factors in Moyamoya Disease.
Fang YC; Wei LF; Hu CJ; Tu YK
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567654
[TBL] [Abstract][Full Text] [Related]
16. Panobinostat, a histone deacetylase inhibitor, rescues the angiogenic potential of endothelial colony-forming cells in moyamoya disease.
Jangra A; Choi SA; Koh EJ; Moon YJ; Wang KC; Phi JH; Lee JY; Kim SK
Childs Nerv Syst; 2019 May; 35(5):823-831. PubMed ID: 30815722
[TBL] [Abstract][Full Text] [Related]
17. Adult moyamoya disease in the asymptomatic Japanese population.
Ikeda K; Iwasaki Y; Kashihara H; Hosozawa K; Anan K; Tamura M; Satoyoshi E; Ikeda H
J Clin Neurosci; 2006 Apr; 13(3):334-8. PubMed ID: 16540331
[TBL] [Abstract][Full Text] [Related]
18. A nationwide survey on unilateral moyamoya disease in Japan.
Hayashi K; Horie N; Izumo T; Nagata I
Clin Neurol Neurosurg; 2014 Sep; 124():1-5. PubMed ID: 24976021
[TBL] [Abstract][Full Text] [Related]
19. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
[TBL] [Abstract][Full Text] [Related]
20. Endothelial Progenitor Cells Induce Angiogenesis: a Potential Mechanism Underlying Neovascularization in Encephaloduroarteriosynangiosis.
Wang QN; Zou ZX; Wang XP; Zhang Q; Zhao YQ; Duan L; Bao XY
Transl Stroke Res; 2021 Apr; 12(2):357-365. PubMed ID: 32632776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
